In the study cohort of 1,040,341 drug-naive individuals with T2DM without prior LC diagnosis, significant differences were observed between the exposure and comparison cohorts (non-insulin antidiabetic drugs versus insulin) across several parameters. This evidence concerns the gene INS and laryngotracheoesophageal cleft.